Phase 3 Prurigo Nodularis Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis
Prurigo Nodularis
Guangdong Hengrui Pharmaceutical Co., Ltd423 enrolled1 locationNCT06554509
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)
Prurigo Nodularis
Incyte Corporation330 enrolled119 locationsNCT06516965
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)
Prurigo Nodularis
Incyte Corporation330 enrolled120 locationsNCT06516952
Recruiting
Phase 3
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
Prurigo Nodularis
Sanofi18 enrolled14 locationsNCT06293053
Recruiting
Phase 3
Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis
Prurigo Nodularis
Shanghai Mabgeek Biotech.Co.Ltd160 enrolled1 locationNCT06779136